serum enterolactone levels mortality outcome women early breast cancer retrospective cohort study pubmed ncbi abstract previously demonstrated high serum enterolactone levels reduced incidence breast cancer healthy women present study aimed investigating similar association found serum enterolactone levels mortality women early breast cancer levels enterolactone cryopreserved serum aliquots obtained num patients operated breast cancer measured time-resolved fluoro-immunoassay levels analyzed respect risk mortality surgery cox proportional hazard regression models check prognostic features estimate hazard ratios group comparisons test interaction mortality hazards variables enterolactone concentrations fine gray competing risk proportional hazard regression model predict probabilities breast cancer-related breast cancer-unrelated mortalities median follow-up time num years range num num num patients died num died due breast cancer-related events association decreased mortality risk enterolactone levels num nmol/l found respect all-cause breast cancer-specific mortality difference mortality hazards statistically significant appeared decrease lose significance num years competing risk analysis showed breast cancer-related mortality risk remained constantly lower patients higher enterolactone levels findings consistent recent literature provide evidence mammalian lignans play important role reducing all-cause cancer-specific mortality patients operated breast cancer 
